Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/103985| Title: | Medicinal cannabis use in rare diseases |
| Authors: | Parovincaka, Jekaterina Vella Szijj, Janis Serracino-Inglott, Anthony |
| Keywords: | Rare diseases Cannabinoids Cannabis Patients |
| Issue Date: | 2022 |
| Publisher: | International Pharmaceutical Federation |
| Citation: | Parovincaka, J., Vella Szijj, J., & Serracino Inglott, A. (2022). Medicinal cannabis use in rare diseases. 80th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Seville. |
| Abstract: | Rare diseases (RDs) affect over 300 million people worldwide. There are approximately 7,000 recognised RDs. RDs are usually genetic and are associated with severe debilitating symptoms which persist for a patient’s lifetime. RD patients face multiple challenges including delay in accurate diagnosis and significant unmet need for beneficial therapies. For 90 % of RDs there are no effective therapies. Medicinal Cannabis (MC) is used to relieve symptoms, such as pain, muscle spasticity and anxiety, which may be commonly experienced by patients with RDs. Being able to manage the symptoms and the progression of diseases, can positively impact patients, families and health care systems. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/103985 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Medicinal_cannabis_use_in_rare_diseases_2022.pdf | 413.37 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.